Aigen Investment Management, LP

Position in LLY — ELI LILLY & Co

CIK 1741224 NEW YORK, NY

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,321,771

-$583,072 QoQ

Shares Held

1,102

-46.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#2,870

of 4,605 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aigen Investment Management, LP holds $6,988,444 across 5 Drug Manufacturers - General names. LLY ranks #2 (18.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	29,983	$3,788,052
2	LLY	ELI LILLY & Co This page	1,102	$1,321,771
3	JNJ	Johnson & Johnson	3,601	$914,545
4	SNY	Sanofi	14,359	$612,554
5	NVS	Novartis AG	2,243	$351,522

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,321,771	1,102	-46.8%	Shares	Sole	2026-08-14
2026-03-31	$1,904,843	2,071	+161.5%	Shares	Sole	2026-05-15
2025-06-30	$617,387	792	-51.1%	Shares	Sole	2025-08-12
2024-09-30	$1,433,450	1,618	-81.0%	Shares	Sole	2024-11-05
2024-03-31	$6,628,219	8,520	+81.5%	Shares	Sole	2024-05-14
2022-06-30	$1,521,611	4,693	-55.4%	Shares	Sole	2022-08-02
2022-03-31	$3,016,335	10,533	+54.1%	Shares	Sole	2022-05-05
2021-12-31	$1,888,516	6,837	+151.0%	Shares	Sole	2022-02-11
2021-03-31	$508,897	2,724	-58.6%	Shares	Sole	2021-05-11
2020-09-30	$974,859	6,586	+25.4%	Shares	Sole	2020-11-06
2020-03-31	$728,418	5,251	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.